Evercore Wealth Management, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
Evercore Wealth Management, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2017$6,000
+50.0%
3000.0%0.00%
Q3 2017$4,000
-20.0%
3000.0%0.00%
Q2 2017$5,000
+66.7%
3000.0%0.00%
Q1 2017$3,000
-25.0%
3000.0%0.00%
Q4 2016$4,000
-42.9%
3000.0%0.00%
Q3 2016$7,000
+16.7%
3000.0%0.00%
Q2 2016$6,000
-83.8%
300
-78.8%
0.00%
-100.0%
Q1 2016$37,000
-74.3%
1,4150.0%0.00%
-71.4%
Q4 2015$144,000
-72.0%
1,415
-50.8%
0.01%
-72.0%
Q3 2015$514,000
-19.7%
2,8750.0%0.02%
-13.8%
Q2 2015$640,000
+28.8%
2,875
+15.5%
0.03%
+26.1%
Q1 2015$497,000
+99.6%
2,490
+43.0%
0.02%
+91.7%
Q4 2014$249,000
+29.7%
1,741
+18.4%
0.01%
+20.0%
Q3 2014$192,000
+3.8%
1,4700.0%0.01%0.0%
Q2 2014$185,000
-4.6%
1,4700.0%0.01%
-9.1%
Q1 2014$194,000
+288.0%
1,470
+241.9%
0.01%
+266.7%
Q4 2013$50,000
+900.0%
430
+795.8%
0.00%
Q3 2013$5,000
-99.5%
48
-99.6%
0.00%
-100.0%
Q2 2013$1,022,00011,8670.06%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2016
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders